IL1B and diabetes mellitus: Increased proinflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-6 (IL-6), promote BRB breakdown and increase microvascular impairment, which contribute to the increase of vascular permeability by different signaling pathways in diabetes-induced retinal pathology 12-14.